
ONDCP Convenes Interdiction Committee on Drug Supply
White House drug policy leaders meet with DHS, DOJ, and intelligence agencies to align operations against fentanyl trafficking and sign updated committee charter.
Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.

White House drug policy leaders meet with DHS, DOJ, and intelligence agencies to align operations against fentanyl trafficking and sign updated committee charter.

New research reveals 20% of U.S. pharmacies refuse to dispense buprenorphine, creating critical barriers to opioid addiction treatment despite federal expansion efforts.

New Jersey will receive $1.1 billion through 2038 from opioid settlements, with funds split between state programs and 262 local governments.

President Trump signed an executive order accelerating psychedelic drug research, directing FDA priority vouchers, Right to Try access, and $50 million in federal-state partnerships.

After years of delay, Mississippi lawmakers finally appropriated opioid settlement funds—but the process exposed deep tensions between community input and political control.

Missouri legislators cut $3 million from naloxone distribution programs, sparking debate over whether lifesaving harm reduction measures have become victims of their own success.

New transparency tool reveals patients face 24-83% fewer in-network options for mental health care, while clinicians earn 16-59% less than physical health providers.

New Pew research reveals 40% of Americans face provider shortages, with rural counties three times more likely to lack psychologists. States respond with loan repayment and pipeline programs.

DEA reports tenfold increase in carfentanil seizures as Chinese precursor crackdown pushes Mexican cartels toward deadlier alternative.